Commonwealth of Pa. v. Purdue Pharma

Supreme Court of Pennsylvania·Decided September 9, 2022·No. 26 EM 2022·Published

Opinion

IN THE SUPREME COURT OF PENNSYLVANIA EASTERN DISTRICT

COMMONWEALTH OF PENNSYLVANIA, : No. 26 EM 2022 ACTING BY AND THROUGH : PHILADELPHIA DISTRICT ATTORNEY : LAWRENCE S. KRASNER, : :

Petitioner : : :

v. : : :

PURDUE PHARMA L.P., ET AL., : :

Respondents : :

CITY OF PHILADELPHIA, : :

Petitioner : : :

v. : : :

ALLERGAN PLC, ET AL., : :

Respondents : :

CITY OF PHILADELPHIA, : :

Petitioner : : :

v. : : :

PAR PHARMACEUTICAL, INC., ET AL., : :

Respondents : :

CITY OF PHILADELPHIA, : :

Petitioner :

: :

v. :

: :

ALLERGAN LTD., ET AL., :

:

Respondents :

:

CITY OF PHILADELPHIA, :

:

Petitioner :

: :

v. :

: :

CVS INDIANA, LLC, ET AL., :

:

Respondents :

ORDER

PER CURIAM

AND NOW, this 9th day of September, 2022, the Application for Leave to Submit

Post-Submission Communication is GRANTED, and the “Application for Extraordinary

Relief under 42 Pa.C.S. §§502 and 726 and Pa.R.A.P. 3309” is DENIED.

[26 EM 2022] - 2

Free access — add to your briefcase to read the full text and ask questions with AI

Commonwealth of Pa. v. Purdue Pharma, (Pa. 2022).

Commonwealth of Pa. v. Purdue Pharma (Commonwealth of Pa. v. Purdue Pharma) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

§ 502
Pennsylvania § 502